相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Behavioural intervention in medication overuse headache: A concealed double-blind randomized controlled trial
Judith A. Pijpers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2022)
Dependence-like behaviour in patients treated for medication overuse headache: A prospective open-label randomized controlled trial
Carolien Rouw et al.
EUROPEAN JOURNAL OF PAIN (2021)
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication-overuse headache: Subgroup analysis of PROMISE-2
Hans-Christoph Diener et al.
HEADACHE (2021)
Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
Messoud Ashina et al.
CEPHALALGIA (2020)
Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide
Leon F. Garcia-Martinez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Comparison of 3 Treatment Strategies for Medication Overuse Headache A Randomized Clinical Trial
Louise Ninett Carlsen et al.
JAMA NEUROLOGY (2020)
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2
Richard B. Lipton et al.
NEUROLOGY (2020)
Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study
Timothy R. Smith et al.
CLINICAL THERAPEUTICS (2020)
Population pharmacokinetic and exposure-response analysis of eptinezumab in the treatment of episodic and chronic migraine
Brian Baker et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)
Migraine Progression: A Systematic Review
Dawn C. Buse et al.
HEADACHE (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Medication-overuse headache: risk factors, pathophysiology and management
Hans-Christoph Diener et al.
NATURE REVIEWS NEUROLOGY (2016)
Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial
Espen Saxhaug Kristoffersen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)
L. Bendtsen et al.
CEPHALALGIA (2014)
Medication-overuse headache: epidemiology, diagnosis and treatment
Espen Saxhaug Kristoffersen et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2014)
Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial
Paolo Rossi et al.
JOURNAL OF HEADACHE AND PAIN (2013)
A randomized controlled trial on medication-overuse headache: outcome after 1 and 4 years
K. Hagen et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Reduction in medication-overuse headache after short information. The Akershus study of chronic headache
R. B. Grande et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Non-pharmacological approaches to treating chronic migraine with medication overuse
F. Andrasik et al.
NEUROLOGICAL SCIENCES (2009)
Nurse-based education: An office-based comparative model for education of migraine patients
Roger Cady et al.
HEADACHE (2008)
Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study
Marcelo E. Bigal et al.
HEADACHE (2008)
分享论文
